Pure Biologics

Pure Biologics FCF per Share

The Free Cash Flow per Share of Pure Biologics (PUR.WA) as of Nov 12, 2026 is -0.77 PLN. In the previous year, Free Cash Flow per Share was -2.89 PLN — a change of -73.36% (higher).

FCF per Share

-0.77PLN

YoY

-73.36%

Last updated:

Free Cash Flow per Share of Pure Biologics is 2025 -0.77 PLN. Free Cash Flow per Share of Pure Biologics was 2024 -2.89 PLN. It decreases by -73.36% higher compared to the previous year.

The Pure Biologics FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-2.26 PLN
Jan 1, 2019
3.13 PLN
Jan 1, 2020
-0.90 PLN
Jan 1, 2021
-10.96 PLN
Jan 1, 2022
-10.27 PLN
Jan 1, 2023
-7.13 PLN
Jan 1, 2024
-2.89 PLN
Jan 1, 2025
-0.77 PLN
The Pure Biologics FCF per Share history
YEARFCF per ShareYoY
-0.77PLN-73.36%
-2.89PLN-59.50%
-7.13PLN-30.59%
-10.27PLN-6.33%
-10.96PLN+1,114.57%
-0.90PLN-128.86%
3.13PLN-238.36%
-2.26PLN-12.00%
-2.57PLN+2,479.11%
-0.10PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

Free Cash Flow per Share of Pure Biologics is -0.77 PLN in 2025.

Free Cash Flow per Share of Pure Biologics changed from -2.89 PLN to -0.77 PLN, representing a -73.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Pure Biologics

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Pure Biologics